Articles dans des revues avec comité de lecture (54)
  1. 12. Wuyts, W., Dahlqvist, C., Slabbynck, H., Schlesser, M., Gusbin, N., Compere, C., Maddens, S., Rizzo, S., Kirchgaessler, K. U., Bartley, K., & Bondue, B. (2022). Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry. Pulmonary Therapy. doi:10.1007/s41030-022-00187-8
  2. 13. Taton, O., Heinen, V., Bondue, B., Slebos, D. J., Shah, P. P., Carron, K., Moens, O., & Leduc, D. (2022). Long-Term Follow-Up of Intralobar Bullae After Endobronchial Valve Treatment for Emphysema. International journal of chronic obstructive pulmonary disease, 17, 1735-1742. doi:10.2147/COPD.S363490
  3. 14. Bondue, B., Schlossmacher, P., Allou, N., Gazaille, V., Taton, O., Gevenois, P.-A., Vandergheynst, F., Remmelink, M., & Leduc, D. (2021). Trans-bronchial lung cryobiopsy in patients at high-risk of complications. BMC pulmonary medicine, 21(1), 135. doi:10.1186/s12890-021-01503-9
  4. 15. Justet, A., Klay, D., Porcher, R., Cottin, V., Ahmad, K., Molina Molina, M., Nunes, H., Reynaud-Gaubert, M., Naccache, J. M., Manali, E. E., Froidure, A., Jouneau, S., Stervinou-Wemeau, L., Andrejak, C., Gondouin, A., Hirschi, S., Blanchard, E., Bondue, B., Bonniaud, P., Tromeur, C., Prévot, G., Marchand-Adam, S., Funke-Chambour, M., Gamez, A. S., Ba, I., Papiris, S., Grutters, J. J., Crestani, B., Van Moorsel, C., Kannengiesser, C., Borie, R., & OrphaLung Network, (2021). Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation. The European respiratory journal, 57(2). doi:10.1183/13993003.03198-2020
  5. 16. Tiezzi, M., Morra, S., Seminerio, J., Van Muylem, A., Godefroid, A., Law-Weng-Sam, N., Van Praet, A., Corbiere, V., Orte Cano, C., Karimi, S., Del Marmol, V., Bondue, B., Benjelloun, M., Lavis, P., Mascart, F., Van De Borne, P., & Cardozo, A. K. (2021). SP-D and CC-16 Pneumoproteins' Kinetics and Their Predictive Role During SARS-CoV-2 Infection. Frontiers in Medicine, 8, 761299. doi:10.3389/fmed.2021.761299
  6. 17. Bondue, B., Leduc, D., Taton, O., & Sokolow, Y. (2020). Lung cancer screening and management of pulmonary nodule. Revue Médicale de Bruxelles, 41, 416-420.
  7. 18. Bondue, B., Leduc, D., Froidure, A., Pieters, T., Taton, O., Heinen, V., Alexander, P., Hoton, D., Dome, F., & Remmelink, M. (2020). Usefulness of surgical lung biopsies after cryobiopsies when pathological results are inconclusive or show a pattern suggestive of a nonspecific interstitial pneumonia. Respiratory research, 21(1), 231. doi:10.1186/s12931-020-01487-w
  8. 19. Wells, A. U., Flaherty, K. R., Brown, K., Inoue, Y., Devaraj, A., Richeldi, L., Moua, T., Crestani, B., Wuyts, W., Stowasser, S., Quaresma, M., Goeldner, R. G., Schlenker-Herceg, R., Bondue, B., INBUILD trial investigators,, & Kolb, M. (2020). Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. The Lancet. Respiratory medicine, 8(5), 453-460. doi:10.1016/S2213-2600(20)30036-9
  9. 20. Taton, O., Papleux, E., Bondue, B., Knoop, C., Van Laethem, S., Bauler, A., Martiny, D., Montesinos Hernandez, I., Delforge, M.-L., Elmaouhab, K., & Leduc, D. (2020). Role of the Bronchoalveolar Lavage in Noncritically Ill Patients during the SARS-CoV-2 Epidemic. Pulmonary Medicine, 2020, 9012187. doi:10.1155/2020/9012187
  10. 21. Rinciog, C., Diamantopoulos, A., Gentilini, A., Bondue, B., Dahlqvist, C., Froidure, A., Wuyts, A., & Soulard, L. (2020). Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium. PharmacoEconomics - open. doi:10.1007/s41669-019-00191-w
  11. 22. Wuyts, W., Dahlqvist, C., Slabbynck, H., Schlesser, M., Gusbin, N., Compere, C., Maddens, S., Lee, Y. C., Kirchgaessler, K. U., Bartley, K., & Bondue, B. (2019). Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: The PROOF registry. Respiratory research, 20(1), 231. doi:10.1186/s12931-019-1182-z
  12. 23. Flaherty, K. R., Wells, A. U., Cottin, V., Devaraj, A., Walsh, S. L. F., Inoue, Y., Richeldi, L., Kolb, M., Tetzlaff, K., Stowasser, S., Coeck, C., Clerisme-Beaty, E., Rosenstock, B., Quaresma, M., Haeufel, T., Goeldner, R. G., Schlenker-Herceg, R., INSTAGE Investigator, B. B., Bondue, B., & Brown, K. (2019). Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. The New England journal of medicine, 381(18), 1718-1727. doi:10.1056/NEJMoa1908681
    13. << Précédent 1 2 3 4 5 6 Suivant >>